About Index Trending news
Analyze
Top 50 Pricing
ThromboGenics

ThromboGenics

Work at ThromboGenics? Add yourself to this profile

ThromboGenics

Delivering next gen treatments for vitreo-retinal disorders, focus on diabetic eye disease. Pioneering pharmacological vitreolysis globally (ocriplasmin owner).

Elsewhere

Alexa global traffic share

Twitter followers

Employees

Team size

50+
Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when ThromboGenics makes some noise.